Our analytical and sequencing technologies can also be applied to characterize and re-engineer sugars that exist on the surface of proteins. We can engineer new forms of sugars by determining how the manufacturing process changes the distribution of sugars present on the protein, thereby changing biological properties. Altering the complex sugar coat of a protein can potentially improve efficacy and tissue targeting, reduce negative side effects, such as allergic reactions, and modify the dosing frequency of protein drugs. We believe our technology will allow us to efficiently engineer desired modifications to existing proteins to address significant unmet needs and capitalize on a number of potential product opportunities.

.